Peng Haixia, Martens Steven, Uvyn Annemiek, Chen Yong, Zhong Zifu, Louage Benoit, De Geest Bruno G
Department of Pharmaceutics, Ghent University, Ghent 9000, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium.
ACS Appl Bio Mater. 2025 Jan 20;8(1):177-188. doi: 10.1021/acsabm.4c00825. Epub 2024 Sep 17.
The strategic engagement of innate immunity is a promising avenue for cancer treatment. Antibody-recruiting molecules (ARMs) direct endogenous antibodies to target tumor sites, eliciting innate immune effector killing responses. In this study, we report the synthesis of ARMs by employing solid-phase peptoid synthesis to construct three libraries of antibody-recruiting oligomers. Using dinitrophenyl (DNP) as a model hapten and alkyl lipid chains for cell surface anchoring, we tailored oligomers with variations in valency and spatial configuration. Among these, an oligomer design featuring DNP connected to the oligomer backbone through an extended PEG linker and flanked by two lipid motifs emerged as the most effective in antibody recruitment in vitro. This oligomer was further functionalized to include an imidazoquinoline, creating a trifunctional hapten-lipid-TLR7/8 agonist oligomer, and a parallel variant was conjugated with rhodamine, resulting in a trifunctional hapten-lipid-dye oligomer. Upon intratumorally administration in a murine model, these oligomers induced localized immune activation within tumors. Subsequent ex vivo analysis of single-cell suspensions from excised tumors confirmed the enhanced binding of anti-DNP antibodies. These findings underscore the potential of custom-designed ARMs in orchestrating precise immune-mediated tumor targeting and highlight the adaptability of solid-phase synthesis in oligomer design for the design of multifunctional antibody recruiting molecules.
激活固有免疫是一种很有前景的癌症治疗途径。抗体招募分子(ARM)可引导内源性抗体靶向肿瘤部位,引发固有免疫效应细胞的杀伤反应。在本研究中,我们报告了通过固相类肽合成构建三个抗体招募寡聚物文库来合成ARM。以二硝基苯基(DNP)作为模型半抗原,并使用烷基脂质链进行细胞表面锚定,我们定制了具有不同价态和空间构型的寡聚物。其中,一种寡聚物设计最为有效,即DNP通过延长的聚乙二醇接头连接到寡聚物主链,并两侧带有两个脂质基序,在体外抗体招募方面表现最佳。该寡聚物进一步功能化,包含一个咪唑喹啉,形成三功能半抗原-脂质-TLR7/8激动剂寡聚物,同时一个平行变体与罗丹明偶联,形成三功能半抗原-脂质-染料寡聚物。在小鼠模型中进行瘤内给药后,这些寡聚物在肿瘤内诱导了局部免疫激活。随后对切除肿瘤的单细胞悬液进行体外分析,证实了抗DNP抗体的结合增强。这些发现强调了定制设计的ARM在精确协调免疫介导的肿瘤靶向方面的潜力,并突出了固相合成在寡聚物设计中的适应性,可用于设计多功能抗体招募分子。